Treatment de-escalation in Philadelphia chromosome–positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens

The management of Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukemia (ALL) has witnessed major progress over the past two decades. Initially, the incorporation of the first-generation BCR::ABL1 tyrosine kinase inhibitor (TKI) imatinib into intensive chemotherapy regimens imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Fadi G., Sawyers, Jacki, Short, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900664/
https://www.ncbi.nlm.nih.gov/pubmed/36755897
http://dx.doi.org/10.1177/20406207231151294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900664/
https://www.ncbi.nlm.nih.gov/pubmed/36755897
http://dx.doi.org/10.1177/20406207231151294

Ejemplares similares